Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Pathology Reporting and AJCC Staging for Primary Cutaneous Melanoma
Description
The presentation focuses on the pathology reporting and AJCC staging for primary cutaneous melanoma, outlining the key features necessary for accurate diagnosis and staging. Emphasizing the relevance of clinical information such as patient age, sex, and biopsy details, the speaker explains the significance of Breslow thickness and ulceration in determining the T categories within the AJCC's 8th edition. Key changes from the previous edition include the introduction of T1A and T1B classifications based on size and ulceration. The presentation also discusses the importance of mitotic figures as prognostic indicators, the classification of nodal disease, and the distinction between clinically evident and occult lymph node metastases. The speaker highlights several prognostic features such as tumor size, location within lymph nodes, and the presence of microsatellites that play a crucial role in staging and predicting patient outcomes. Additionally, the discussion addresses tools and markers used in diagnosis, such as immunohistochemistry and molecular studies like next-generation sequencing, aiding in accurate classification and management of melanoma. Throughout, the speaker underscores the evolving understanding and staging criteria for melanoma, emphasizing collaboration in the pathologic assessment and care for affected patients, and concludes with a personal tribute to a mentor in the field.
View moreConclusions
- AJCC staging for primary cutaneous melanoma is specific and does not apply to other melanoma types such as conjunctival or mucosal.
- The T category for staging is defined by Breslow thickness and the presence or absence of ulceration.
- The major modification in the 8th edition AJCC staging includes a significant cut point at Breslow thickness of 0.8 mm for defining risk categories in T1 melanomas.
- Mitotic rate is a crucial prognostic factor but does not contribute to T category designation in the 8th edition.
- Nodal status, indicated by the N category, and the absence or presence of microsatellites or metastasis are critical in staging and determining prognosis.
- Clinical and pathologic features, including diagnostic imaging, and the biopsy intent, significantly influence the diagnostic process.
- Early stage melanoma patients are categorized into prognostic groups based on their T and N classification, correlating with melanoma-specific survival outcomes.
- Selecting appropriate diagnostic tools and methods, including histopathology and molecular testing, can greatly enhance melanoma diagnosis and staging accuracy.
- Ann Surg Oncol (2018) 25:894-902
- Gershenwald JE et al. CA Journal Clinic. 2017. 67(6):472-492.
- J Clin Oncol 27:6199-6206.
- Cancer 2001:91:983-91.
- Am J Surg Pathol. 2019. 43(10):1442-1444.
- Am J Surg Pathol 2018:42:1456 1465